Guanmin Jiang

7.1k total citations · 6 hit papers
54 papers, 4.7k citations indexed

About

Guanmin Jiang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Guanmin Jiang has authored 54 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 15 papers in Oncology and 15 papers in Immunology. Recurrent topics in Guanmin Jiang's work include RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (9 papers) and COVID-19 Clinical Research Studies (8 papers). Guanmin Jiang is often cited by papers focused on RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (9 papers) and COVID-19 Clinical Research Studies (8 papers). Guanmin Jiang collaborates with scholars based in China, United States and Macao. Guanmin Jiang's co-authors include Xi Huang, Hong Shan, Hongsheng Wang, Yongjian Wu, Lantian Tang, Juan Zheng, Zhimin Lu, Bing‐Hua Jiang, Peter K. Vogt and Tony Hunter and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and ACS Nano.

In The Last Decade

Guanmin Jiang

53 papers receiving 4.6k citations

Hit Papers

Prolonged presence of SARS-CoV-2 viral RNA in faecal samples 2019 2026 2021 2023 2020 2019 2019 2023 2024 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples
    2020 1.1k citations Yongjian Wu, Cheng Guo et al. ˜The œLancet. Gastroenterology & hepatology profile →
  2. Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy
    2019 456 citations Guanmin Jiang et al. profile →
  3. The relationship between autophagy and the immune system and its applications for tumor immunotherapy
    2019 291 citations Guanmin Jiang, Yan Liu et al. Molecular Cancer profile →
  4. Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets
    2023 106 citations Bowen Hu, Hongsheng Wang et al. Signal Transduction and Targeted Therapy profile →
  5. RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
    2024 64 citations Weiwei Liu, Si-Qing Zheng et al. Signal Transduction and Targeted Therapy profile →
  6. Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung
    2025 19 citations Tianchuan Zhu, Shoudeng Chen et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guanmin Jiang China 28 2.4k 1.3k 1.1k 717 693 54 4.7k
Shemin Lu China 36 1.9k 0.8× 798 0.6× 938 0.8× 419 0.6× 427 0.6× 164 5.0k
Wei Zhang China 34 2.0k 0.8× 831 0.7× 475 0.4× 847 1.2× 381 0.5× 264 4.6k
Shuan Rao China 20 1.5k 0.6× 563 0.4× 1.5k 1.3× 465 0.6× 362 0.5× 50 3.9k
Wei Kang China 52 4.9k 2.0× 2.3k 1.8× 1.3k 1.2× 1.5k 2.1× 646 0.9× 169 8.5k
Yi Zeng China 31 1.8k 0.7× 923 0.7× 266 0.2× 657 0.9× 394 0.6× 231 3.6k
Min Yang China 38 2.0k 0.8× 847 0.7× 272 0.2× 821 1.1× 621 0.9× 243 5.0k
Michael A. McNutt China 44 2.5k 1.0× 645 0.5× 553 0.5× 1.1k 1.5× 837 1.2× 105 5.7k
Jie Xiong China 29 1.4k 0.6× 690 0.5× 659 0.6× 562 0.8× 262 0.4× 128 3.2k
Yao Liu China 33 2.1k 0.9× 1.2k 1.0× 305 0.3× 988 1.4× 567 0.8× 194 4.6k
Lin Shen China 32 1.3k 0.5× 479 0.4× 699 0.6× 438 0.6× 550 0.8× 173 3.6k

Countries citing papers authored by Guanmin Jiang

Since Specialization
Citations

This map shows the geographic impact of Guanmin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanmin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanmin Jiang more than expected).

Fields of papers citing papers by Guanmin Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guanmin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanmin Jiang. The network helps show where Guanmin Jiang may publish in the future.

Co-authorship network of co-authors of Guanmin Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Guanmin Jiang. A scholar is included among the top collaborators of Guanmin Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guanmin Jiang. Guanmin Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Tianchuan, et al.. (2025). Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung. Nature Communications. 16(1). 262–262. 19 indexed citations breakdown →
2.
Wang, Qiaohua, Yongjian Wu, Yu Shi, et al.. (2025). AR+TREM2+ macrophage induced pathogenic immunosuppression promotes prostate cancer progression. Nature Communications. 16(1). 6964–6964. 4 indexed citations
3.
Liu, Weiwei, Si-Qing Zheng, Li Tian, et al.. (2024). RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy. Signal Transduction and Targeted Therapy. 9(1). 70–70. 64 indexed citations breakdown →
4.
Liu, Ye, et al.. (2024). m6A Modification Promotes EMT and Metastasis of Castration-Resistant Prostate Cancer by Upregulating NFIB. Cancer Research. 84(12). 1947–1962. 20 indexed citations
5.
Sun, Hui‐Chuan, et al.. (2024). Identification of Molecular Subtype and Prognostic Signature for Prostate Adenocarcinoma based on Neutrophil Extracellular Traps. Journal of Cancer. 15(9). 2678–2690. 3 indexed citations
6.
Ming, Siqi, Yongjian Wu, Jia‐You Wei, et al.. (2023). COVID‐19 Metabolomic‐Guided Amino Acid Therapy Protects from Inflammation and Disease Sequelae. Advanced Biology. 7(8). 4 indexed citations
7.
Hu, Bowen, Yan Liu, Haojie Wang, et al.. (2023). Analysis of Risk Factors for Early Progression of Prostate Cancer After Initial Endocrine Therapy. Journal of Cancer. 14(4). 519–531. 3 indexed citations
8.
Lyu, Hui, Guanmin Jiang, Sanbao Ruan, et al.. (2022). ALKBH5-Mediated m6A Demethylation of GLUT4 mRNA Promotes Glycolysis and Resistance to HER2-Targeted Therapy in Breast Cancer. Cancer Research. 82(21). 3974–3986. 72 indexed citations
9.
Shi, Bin, Weiwei Liu, Ke Yang, Guanmin Jiang, & Hao Wang. (2022). The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer. Molecular Cancer. 21(1). 163–163. 43 indexed citations
10.
Chen, Feng, Zhuojia Chen, Tao Guan, et al.. (2021). N6 -Methyladenosine Regulates mRNA Stability and Translation Efficiency of KRT7 to Promote Breast Cancer Lung Metastasis. Cancer Research. 81(11). 2847–2860. 90 indexed citations
11.
Wu, Yongjian, Xiaomin Cheng, Guanmin Jiang, et al.. (2021). Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. npj Biofilms and Microbiomes. 7(1). 61–61. 139 indexed citations
12.
Liu, Yan, Weifeng Song, Jieying Pu, et al.. (2021). A Novel Role for the Regulatory Nod-Like Receptor NLRP12 in Anti-Dengue Virus Response. Frontiers in Immunology. 12. 744880–744880. 14 indexed citations
13.
He, Juan, Guanmin Jiang, Xing Li, et al.. (2021). Bilirubin represents a negative regulator of ILC2 in allergic airway inflammation. Mucosal Immunology. 15(2). 314–326. 13 indexed citations
14.
Wu, Yingmin, Xiangling Yang, Guanmin Jiang, et al.. (2021). 5′-tRF-GlyGCC: a tRNA-derived small RNA as a novel biomarker for colorectal cancer diagnosis. Genome Medicine. 13(1). 20–20. 96 indexed citations
15.
Kang, Sisi, Mei Yang, Suhua He, et al.. (2021). A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation. Nature Communications. 12(1). 2697–2697. 59 indexed citations
16.
Wu, Yongjian, Cheng Guo, Lantian Tang, et al.. (2020). Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. ˜The œLancet. Gastroenterology & hepatology. 5(5). 434–435. 1104 indexed citations breakdown →
17.
Mao, Minjie, Ao Zhang, Yi He, et al.. (2020). Development and validation of a novel nomogram to predict overall survival in gastric cancer with lymph node metastasis. International Journal of Biological Sciences. 16(7). 1230–1237. 9 indexed citations
18.
Wu, Yingmin, Xiangling Yang, Zhuojia Chen, et al.. (2019). m6A-induced lncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1. Molecular Cancer. 18(1). 87–87. 307 indexed citations
19.
20.
Liang, Shuwei, Zhuojia Chen, Guanmin Jiang, et al.. (2016). Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals. Cancer Letters. 386. 12–23. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shemin Lu Breakdown of academic impact, for papers by Wei Zhang Breakdown of academic impact, for papers by Shuan Rao Breakdown of academic impact, for papers by Wei Kang Breakdown of academic impact, for papers by Yi Zeng Breakdown of academic impact, for papers by Min Yang Breakdown of academic impact, for papers by Michael A. McNutt Breakdown of academic impact, for papers by Jie Xiong Breakdown of academic impact, for papers by Yao Liu Breakdown of academic impact, for papers by Lin Shen
Rankless by CCL
2026